Anterior Segment Changes After Phacoemulsification in Cataractous Eyes with Shallow Anterior Chamber
2 other identifiers
interventional
24
1 country
1
Brief Summary
Phacoemulsification in shallow anterior chamber is considered to be more hazardous regarding risk of intraoperative and postoperative complications. Limited anterior pars plana vitrectomy can be combined with phacoemulsification to deepen the anterior chamber and facilitate surgical steps
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2024
CompletedFirst Submitted
Initial submission to the registry
December 6, 2024
CompletedFirst Posted
Study publicly available on registry
December 20, 2024
CompletedDecember 20, 2024
December 1, 2024
1.9 years
December 6, 2024
December 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Central corneal thickness in micrometers.
Central corneal thickness in both groups measured by anterior segment OCT
6 months
Study Arms (2)
Cataract with limited anterior pars plana vitrectomy
ACTIVE COMPARATORgroup I included twelve patients who underwent phacoemulsification combined with limited anterior pars plana vitrectomy
Cataract without limited anterior pars plana vitrectomy
ACTIVE COMPARATORgroup II included twelve patients that underwent phacoemulsification only
Interventions
Cataract with limited anterior pars plana vitrectomy
cataract without limited anterior pars plana vitrectomy
Eligibility Criteria
You may qualify if:
- Anterior chamber depth of less than 2.8 mm associated with cataract
You may not qualify if:
- Mature cataract
- History of previous ocular surgery
- Posterior segment pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University
Zagazig, Sharqia Province, 44511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mahmoud Mohammad Gamal Mohammad Gamal, MBBCh
Zagazig University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2024
First Posted
December 20, 2024
Study Start
March 22, 2022
Primary Completion
February 2, 2024
Study Completion
June 24, 2024
Last Updated
December 20, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share